IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OFCANCER AND MYELOID-MEDIATED DISEASES
Technology
E-009-2023
Patent ID
E-009-2023-0-PC-01
Country
PCT
Application Type
PCT
Patent Status
Pending
Patent Number
Publication Number
Application Number
PCT/US2023/078854
IC
NCI
Date Filed
Date Issued
Patent PDF